Browsing by Author "Bessone, Fernando."
Now showing items 1-5 of 5
-
Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver
Mendizabal, Manuel.; Silva, Marcelo.; Bessone, Fernando.; Et al. (Elsevier, 2021-09)Abstract Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) is an uncommon cause of liver disease presenting with a wide range of phenotypes and disease severity, ... -
Hepatitis C virus infection in Argentina: Burden of chronic disease.
Ridruejo, Ezequiel.; Bessone, Fernando.; Daruich, Jorge.; Estes, Chris.; Gadano, Adrián.; Razavi, Homie.; Villamil, Federico.; Silva, Marcelo. (Baishideng Publishing Group, 2016-05-28)AIM: To estimate the progression of the hepatitis C virus (HCV) epidemic and measure the burden of HCV-related morbidity and mortality. METHODS: Age- and gender-defined cohorts were used to follow the viremic population ... -
Hepatotoxicity Induced by Coxibs: How Concerned Should We Be?
Bessone, Fernando.; Hernandez, Nelia.; Roma, Marcelo.; Ridruejo, Ezequiel.; Mendizabal, Manuel.; et al. (Taylor & Francis, 2016-08-26)Introduction: The selective inhibitors of COX-2, coxibs, are nonsteroidal anti-inflammatory drugs (NSAIDs) that have much better gastrointestinal safety profile as compared with non-selective NSAIDs. In this review, we ... -
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative.
Bessone, Fernando.; Hernandez, Nelia.; Lucena, Isabel.; Andrade, Raul.; Piñero, Federico.; Mendizabal, Manuel. (MDPI, 2016-02-25)Drug induced liver injury (DILI) is a rare but well recognized serious adverse reaction. Pre-marketing studies may not detect liver injury, and DILI becomes very often apparent after the drug is launched to the market. ... -
Serious liver injury induced by Nimesulide: an international collaborative study
Mendizabal, Manuel.; Bessone, Fernando.; Nelia, Nelia.; Et al. (Springer, 2021-04)Abstract Nimesulide is a non-steroidal anti-inflammatory drug still marketed in many countries. We aim to analyze the clinical phenotype, outcome, and histological features of nimesulide-induced liver injury (nimesulide-DILI). ...